Literature DB >> 22130803

Expansion of functionally defined mouse hematopoietic stem and progenitor cells by a short isoform of RUNX1/AML1.

Shinobu Tsuzuki1, Masao Seto.   

Abstract

Self-renewal activity is essential for the maintenance and regeneration of the hematopoietic system. The search for molecules capable of promoting self-renewal and expanding hematopoietic stem cells (HSCs) has met with limited success. Here, we show that a short isoform (AML1a) of RUNX1/AML1 has such activities. Enforced AML1a expression expanded functionally defined HSCs, with an efficiency that was at least 20 times greater than that of the control in vivo and by 18-fold within 7 days ex vivo. The ex vivo-expanded HSCs could repopulate hosts after secondary transplantations. Moreover, AML1a expression resulted in vigorous and long-term (> 10(6)-fold at 4 weeks) ex vivo expansion of progenitor cell populations capable of differentiating into multilineages. Gene expression analysis revealed that AML1a expression was associated with up-regulation of genes, including Hoxa9, Meis1, Stat1, and Ski. shRNA-mediated silencing of these genes attenuated AML1a-mediated activities. Overall, these findings establish AML1a as an isoform-specific molecule that can influence several transcriptional regulators associated with HSCs, leading to enhanced self-renewal activity and hematopoietic stem/progenitor cell expansion ex vivo and in vivo. Therefore, the abilities of AML1a may have implications for HSC transplantation and transfusion medicine, given that the effects also can be obtained by cell-penetrating AML1a protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130803     DOI: 10.1182/blood-2011-06-362277

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

Authors:  Dan Ran; Kentson Lam; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

2.  Accurate germline RUNX1 variant interpretation and its clinical significance.

Authors:  Simone Feurstein; Liying Zhang; Courtney D DiNardo
Journal:  Blood Adv       Date:  2020-12-22

3.  Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms.

Authors:  Hiroko Sakurai; Yuka Harada; Yosuke Ogata; Yuki Kagiyama; Naoki Shingai; Noriko Doki; Kazuteru Ohashi; Toshio Kitamura; Norio Komatsu; Hironori Harada
Journal:  Blood Adv       Date:  2017-07-31

4.  A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation.

Authors:  Amanda G Davis; Jaclyn M Einstein; Dinghai Zheng; Nathan D Jayne; Xiang-Dong Fu; Bin Tian; Gene W Yeo; Dong-Er Zhang
Journal:  Blood Adv       Date:  2021-03-09

5.  The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells.

Authors:  Patrick I Ferrell; Jiafei Xi; Chao Ma; Mitali Adlakha; Dan S Kaufman
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

6.  Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice.

Authors:  Yukiko Komeno; Ming Yan; Shinobu Matsuura; Kentson Lam; Miao-Chia Lo; Yi-Jou Huang; Daniel G Tenen; James R Downing; Dong-Er Zhang
Journal:  Blood       Date:  2014-04-25       Impact factor: 22.113

7.  Maternal smoking and DNA methylation in newborns: in utero effect or epigenetic inheritance?

Authors:  Bonnie R Joubert; Siri E Håberg; Douglas A Bell; Roy M Nilsen; Stein Emil Vollset; Oivind Midttun; Per Magne Ueland; Michael C Wu; Wenche Nystad; Shyamal D Peddada; Stephanie J London
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-16       Impact factor: 4.254

8.  ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.

Authors:  Xi Luo; Simone Feurstein; Shruthi Mohan; Christopher C Porter; Sarah A Jackson; Sioban Keel; Michael Chicka; Anna L Brown; Chimene Kesserwan; Anupriya Agarwal; Minjie Luo; Zejuan Li; Justyne E Ross; Panagiotis Baliakas; Daniel Pineda-Alvarez; Courtney D DiNardo; Alison A Bertuch; Nikita Mehta; Tom Vulliamy; Ying Wang; Kim E Nichols; Luca Malcovati; Michael F Walsh; Lesley H Rawlings; Shannon K McWeeney; Jean Soulier; Anna Raimbault; Mark J Routbort; Liying Zhang; Gabriella Ryan; Nancy A Speck; Sharon E Plon; David Wu; Lucy A Godley
Journal:  Blood Adv       Date:  2019-10-22

9.  Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.

Authors:  I Sloma; S Imren; P A Beer; Y Zhao; V Lecault; D Leung; K Raghuram; C Brimacombe; K Lambie; J Piret; C Hansen; R K Humphries; C J Eaves
Journal:  Leukemia       Date:  2012-07-16       Impact factor: 11.528

Review 10.  The Molecular Genetics of Myeloproliferative Neoplasms.

Authors:  Anna E Marneth; Ann Mullally
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.